PI
Specialization
medical oncology
Focus of research
Upper gastro-intestinal oncology, with special focus on pancreatic cancer
Cancer and metabolism
-
RE: Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Molenaar, R. J., Radivoyevitch, T. & Wilmink, J. W., 2017, In: Journal of the National Cancer Institute. 109, 8, p. djx103Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Preoperative chemoradiation therapy in combination with panitumumab for patients with resectable esophageal cancer: the PACT study
Kordes, S., van Berge Henegouwen, M. I., Hulshof, M. C., Bergman, J. J. G. H. M., van der Vliet, H. J., Kapiteijn, E., van Laarhoven, H. W. M., Richel, D. J., Klinkenbijl, J. H. G., Meijer, S. L. & Wilmink, J. W., 2014, In: International Journal of Radiation Oncology, Biology, Physics. 90, 1, p. 190-196Research output: Contribution to journal › Article* › Academic › peer-review
-
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Kordes, S., Pollak, M. N., Zwinderman, A. H., Mathôt, R. A., Weterman, M. J., Beeker, A., Punt, C. J., Richel, D. J. & Wilmink, J. W., 2015, In: lancet oncology. 16, 7, p. 839-847Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
-
Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)
Dutch Pancreatic Cancer Group, 1 Dec 2023, In: BMC Cancer. 23, 1, 70.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) (Trials, (2022), 23, 1, (913), 10.1186/s13063-022-06829-1)
Dutch Pancreatic Cancer Group, 1 Dec 2023, In: Trials. 24, 1, 55.Research output: Contribution to journal › Comment/Letter to the editor* › Academic
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial
APACT Investigators, 10 Apr 2023, In: Journal of clinical oncology. 41, 11, p. 2007-2019 13 p.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications